BHP's Copper Surge Fuels Stock Rally, Iron Ore Concerns Linger
Earnings James Calloway

BHP's Copper Surge Fuels Stock Rally, Iron Ore Concerns Linger

BHP Group shares advanced as copper earnings led a half-year profit beat, with the miner setting a 73-cent interim dividend. Analysts note a raised price target but flag iron ore risks.

BHP RIO FCX GLD SLV XLE
CBA Shares Recover Post-Dividend as Labor Data Fuels RBA Speculation
Markets Daniel Marsh

CBA Shares Recover Post-Dividend as Labor Data Fuels RBA Speculation

Commonwealth Bank of Australia shares gained 0.7% to A$178.19, recovering after trading ex-dividend. The move came as Australia's unemployment rate held at 4.1% in January, maintaining scrutiny on the Reserve Bank's interest rate path.

CBAUF MCHI XLF
Telstra Surges on Enhanced Shareholder Returns and Solid Earnings
Earnings James Calloway

Telstra Surges on Enhanced Shareholder Returns and Solid Earnings

Telstra shares climbed 3.8% after the telecom giant increased its share buyback program to A$1.25 billion and raised its interim dividend. The company reported a first-half profit of A$1.124 billion on A$11.64 billion in revenue.

TLS
NAB Shares Hit Record High on Strong Q1 Earnings, Capital in Focus
Earnings James Calloway

NAB Shares Hit Record High on Strong Q1 Earnings, Capital in Focus

National Australia Bank shares reached a new all-time high following a robust first-quarter update showing a 15% rise in cash earnings. Attention now shifts to capital management and the upcoming half-year results.

EWA
Westpac Leads Bank Rally as Robust Jobs Data Fuels RBA Rate Speculation
Markets Daniel Marsh

Westpac Leads Bank Rally as Robust Jobs Data Fuels RBA Rate Speculation

Westpac Banking Corp led Australian financials higher, climbing 2.7% after January jobs data showed unemployment holding at 4.1%. Investors now await key inflation figures and the Reserve Bank's policy decision.

ANZBY CBAUF MCHI XLF
Hinge Health Buyback Signals Undervaluation Amid Mixed Stock Performance
Analysis Daniel Marsh

Hinge Health Buyback Signals Undervaluation Amid Mixed Stock Performance

Hinge Health's significant share buyback underscores management confidence despite a valuation gap and mixed short-term stock performance. Pool Inc and Spin Master also present valuation disparities amid shifting market sentiment.

HNGE POOL
ASX 200 Reclaims 9,000 as NAB Hits Record High on Strong Earnings
Markets Daniel Marsh

ASX 200 Reclaims 9,000 as NAB Hits Record High on Strong Earnings

The Australian benchmark index closed above 9,000 points, lifted by robust banking results and technology gains. National Australia Bank reached an all-time high following a solid quarterly performance.

XLF XLK
FTSE 100 Climbs to New Peak on Cooling UK Inflation
Markets Daniel Marsh

FTSE 100 Climbs to New Peak on Cooling UK Inflation

London's FTSE 100 index surged to a new all-time high after UK inflation data showed a welcome cooldown, strengthening expectations for an imminent Bank of England interest rate cut.

BAESY GLNCY
Anglo American Rises on UK Inflation Data Ahead of Key Results
Markets Daniel Marsh

Anglo American Rises on UK Inflation Data Ahead of Key Results

Anglo American's stock climbed 2.3% in London trading following a slowdown in UK inflation to 3.0%, with markets focused on the company's upcoming annual results and revised copper guidance.

NGLOY
Haleon Gains as UK Inflation Eases, Focus Shifts to Upcoming Earnings
Earnings James Calloway

Haleon Gains as UK Inflation Eases, Focus Shifts to Upcoming Earnings

Haleon's stock advanced 0.9% as UK inflation slowed, fueling expectations for Bank of England rate cuts. Investors now await the company's full-year earnings report on February 25.

EWU
GSK Gains on EU Asthma Drug Approval and £450M Share Repurchase
Regulation James Calloway

GSK Gains on EU Asthma Drug Approval and £450M Share Repurchase

GSK shares advanced after the European Commission approved its asthma drug Exdensur and the company launched a £450 million share repurchase. New data also highlighted the effectiveness of its RSV vaccine.

GSK
BrewDog Considers Sale, Crowdfunding Investors Face Potential Losses
Analysis Daniel Marsh

BrewDog Considers Sale, Crowdfunding Investors Face Potential Losses

BrewDog has engaged advisors to examine potential sale or restructuring, potentially leaving its 220,000 crowdfunding investors with minimal returns. The craft brewer reported significant losses amid challenging market conditions.